Mitochondrial apoptosis-related gene polymorphisms are associated with responses to anthracycline-based chemotherapy in acute myeloid leukaemia
BackgroundAlthough anthracyclines are the first-line chemotherapy drugs for treating non-M3 acute myeloid leukaemia (AML), their efficacy remains limited. It is important to identify factors that influence the efficacy of anthracyclines against AML. Mitochondrial apoptosis-related genes play signifi...
Main Authors: | Guangqiang Meng, Mingying Li, Yuan Xia, Yuyan Wu, Yuechan Ma, Min Ji, Jingru Zhang, Jingjing Ye, Tao Sun, Chunyan Ji |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1179937/full |
Similar Items
-
Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia
by: Yuyan Wu, et al.
Published: (2023-09-01) -
KLK2 single-nucleotide polymorphism rs198977 is associated with increased susceptibility and hyperleukocytosis in AML
by: Guangqiang Meng, et al.
Published: (2023-08-01) -
Acute myeloid leukemia presenting with hepatic dysfunction: Should induction be dose reduced?
by: Satish Maharaj, et al.
Published: (2024-10-01) -
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients
by: Xiaohang Qiao, et al.
Published: (2024-06-01) -
DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA
by: Juan Eduardo Megias-Vericat, et al.
Published: (2019-02-01)